Revvity Inc. (NYSE:RVTY) Receives $108.92 Consensus PT from Brokerages

Revvity Inc. (NYSE:RVTY) has been assigned an average recommendation of “Hold” from the sixteen analysts that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $108.9167.

RVTY has been the subject of several research reports. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Sanford C. Bernstein initiated coverage on Revvity in a report on Friday, June 26th. They issued a “market perform” rating and a $115.00 price objective on the stock. Wolfe Research began coverage on Revvity in a research note on Tuesday, June 2nd. They issued a “peer perform” rating for the company. TD Cowen restated a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Finally, Robert W. Baird set a $117.00 price target on Revvity in a research report on Wednesday, May 6th.

Revvity Stock Up 3.6%

RVTY stock opened at $110.31 on Friday. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. The company’s 50 day moving average is $103.92 and its 200 day moving average is $99.33. The stock has a market cap of $12.31 billion, a price-to-earnings ratio of 52.78, a price-to-earnings-growth ratio of 2.09 and a beta of 1.09. Revvity has a 1-year low of $81.22 and a 1-year high of $118.30.

Revvity (NYSE:RVTY) last announced its earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The business had revenue of $711.12 million during the quarter, compared to analyst estimates of $704.07 million. During the same period in the previous year, the business posted $1.01 earnings per share. Revvity’s revenue for the quarter was up 7.0% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Sell-side analysts predict that Revvity will post 5.25 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, July 17th. Revvity’s payout ratio is presently 13.40%.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Ascentis Independent Advisors purchased a new position in shares of Revvity during the first quarter valued at approximately $29,000. CYBER HORNET ETFs LLC bought a new position in shares of Revvity in the 2nd quarter worth about $32,000. Cromwell Holdings LLC increased its stake in shares of Revvity by 141.4% during the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock valued at $33,000 after purchasing an additional 198 shares in the last quarter. MUFG Securities EMEA plc bought a new position in Revvity during the 2nd quarter valued at approximately $34,000. Finally, Headlands Technologies LLC bought a new position in shares of Revvity during the second quarter valued at $49,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.